FI114707B - Menetelmä terapeuttisesti käyttökelpoisten 3'-kinuklidinyyli-2-(hydroksimetyyli)-2-fenyylialkanoaattijohdannaisten valmistamiseksi ja välituote - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten 3'-kinuklidinyyli-2-(hydroksimetyyli)-2-fenyylialkanoaattijohdannaisten valmistamiseksi ja välituote Download PDF

Info

Publication number
FI114707B
FI114707B FI941170A FI941170A FI114707B FI 114707 B FI114707 B FI 114707B FI 941170 A FI941170 A FI 941170A FI 941170 A FI941170 A FI 941170A FI 114707 B FI114707 B FI 114707B
Authority
FI
Finland
Prior art keywords
formula
compound
compounds
quinuclidinyl
preparation
Prior art date
Application number
FI941170A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI941170A0 (fi
FI941170A (fi
Inventor
Peter Edward Cross
Alan Stobie
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI941170A0 publication Critical patent/FI941170A0/fi
Publication of FI941170A publication Critical patent/FI941170A/fi
Application granted granted Critical
Publication of FI114707B publication Critical patent/FI114707B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
FI941170A 1991-09-14 1994-03-11 Menetelmä terapeuttisesti käyttökelpoisten 3'-kinuklidinyyli-2-(hydroksimetyyli)-2-fenyylialkanoaattijohdannaisten valmistamiseksi ja välituote FI114707B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB919119705A GB9119705D0 (en) 1991-09-14 1991-09-14 Therapeutic compounds
GB9119705 1991-09-14
EP9202067 1992-09-03
PCT/EP1992/002067 WO1993006098A1 (en) 1991-09-14 1992-09-03 Quinuclidine esters process and intermediate for their preparation and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
FI941170A0 FI941170A0 (fi) 1994-03-11
FI941170A FI941170A (fi) 1994-03-11
FI114707B true FI114707B (fi) 2004-12-15

Family

ID=10701448

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941170A FI114707B (fi) 1991-09-14 1994-03-11 Menetelmä terapeuttisesti käyttökelpoisten 3'-kinuklidinyyli-2-(hydroksimetyyli)-2-fenyylialkanoaattijohdannaisten valmistamiseksi ja välituote

Country Status (31)

Country Link
US (1) US5543419A (ru)
EP (1) EP0603229B1 (ru)
JP (2) JP2672030B2 (ru)
KR (1) KR0135784B1 (ru)
CN (1) CN1037269C (ru)
AT (1) ATE167187T1 (ru)
AU (1) AU659487B2 (ru)
BR (1) BR9206499A (ru)
CA (1) CA2116356C (ru)
CZ (1) CZ281752B6 (ru)
DE (1) DE69225897T2 (ru)
DK (1) DK0603229T3 (ru)
EG (1) EG20072A (ru)
ES (1) ES2116343T3 (ru)
FI (1) FI114707B (ru)
GB (1) GB9119705D0 (ru)
GR (1) GR3027667T3 (ru)
HU (1) HU220594B1 (ru)
IL (1) IL103078A (ru)
MX (1) MX9205221A (ru)
MY (1) MY108602A (ru)
NO (1) NO305397B1 (ru)
NZ (1) NZ244324A (ru)
PL (1) PL170627B1 (ru)
PT (1) PT100863B (ru)
RU (1) RU2117669C1 (ru)
SG (1) SG50414A1 (ru)
TW (1) TW251285B (ru)
UA (1) UA42686C2 (ru)
WO (1) WO1993006098A1 (ru)
ZA (1) ZA926939B (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE194342T1 (de) 1996-01-19 2000-07-15 Lonza Ag Verfahren zur herstellung von optisch aktivem 3- chinuclidinol
CZ54498A3 (cs) * 1997-03-07 1998-11-11 Lonza Ag Katalyzátorová směs na bázi amorfního částečně dehydratovaného hydroxidu zirkoničitého a způsob její výroby a použití
JP2001513495A (ja) * 1997-08-08 2001-09-04 デューク ユニバーシティ 外科的処置を容易にする組成物、装置および方法
US6711436B1 (en) 1997-08-08 2004-03-23 Duke University Compositions, apparatus and methods for facilitating surgical procedures
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
DK1345937T3 (da) 2000-12-22 2006-01-16 Almirall Prodesfarma Ag Quinuclidincarbamatderivater og deres anvendelse som M3-antagonister
CZ301209B6 (cs) 2000-12-28 2009-12-09 Laboratorios Almirall, S.A. Nové chinuklidinové deriváty a medicinální kompozice s jejich obsahem
DE102004057995A1 (de) * 2004-12-01 2006-06-08 Wacker Chemie Ag Verfahren zur Herstellung von α,α-Dialkyl-α-Hydroxymethyl-Carbonsäurederivaten
US20100112061A1 (en) * 2006-12-13 2010-05-06 William Baker Monophosphates as Mutual Prodrugs of Muscarinic Receptor Antagonists and Beta-Agonists for the Treatment of COPD And Chronic Bronchitis
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843074A (en) * 1988-05-17 1989-06-27 Marion Laboratories, Inc. 1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts
GB8923590D0 (en) * 1989-10-19 1989-12-06 Pfizer Ltd Antimuscarinic bronchodilators

Also Published As

Publication number Publication date
RU2117669C1 (ru) 1998-08-20
DK0603229T3 (da) 1998-10-12
JP2955533B2 (ja) 1999-10-04
GB9119705D0 (en) 1991-10-30
MX9205221A (es) 1993-03-01
DE69225897T2 (de) 1998-10-15
FI941170A0 (fi) 1994-03-11
CZ281752B6 (cs) 1997-01-15
EG20072A (en) 1999-06-30
TW251285B (ru) 1995-07-11
NO940905D0 (no) 1994-03-14
PT100863A (pt) 1993-10-29
SG50414A1 (en) 1998-07-20
EP0603229B1 (en) 1998-06-10
UA42686C2 (ru) 2001-11-15
JPH09315970A (ja) 1997-12-09
AU659487B2 (en) 1995-05-18
WO1993006098A1 (en) 1993-04-01
HUT66772A (en) 1994-12-28
CN1037269C (zh) 1998-02-04
CZ395392A3 (en) 1994-07-13
HU220594B1 (hu) 2002-03-28
JP2672030B2 (ja) 1997-11-05
IL103078A (en) 1996-07-23
HU9400729D0 (en) 1994-06-28
KR0135784B1 (ko) 1998-04-23
FI941170A (fi) 1994-03-11
IL103078A0 (en) 1993-02-21
CA2116356A1 (en) 1993-04-01
CN1070911A (zh) 1993-04-14
DE69225897D1 (de) 1998-07-16
US5543419A (en) 1996-08-06
BR9206499A (pt) 1995-11-21
EP0603229A1 (en) 1994-06-29
PT100863B (pt) 1999-07-30
NO940905L (no) 1994-03-14
ZA926939B (en) 1994-03-11
JPH06510991A (ja) 1994-12-08
GR3027667T3 (en) 1998-11-30
AU2482392A (en) 1993-04-27
ATE167187T1 (de) 1998-06-15
MY108602A (en) 1996-10-31
NZ244324A (en) 1993-12-23
ES2116343T3 (es) 1998-07-16
NO305397B1 (no) 1999-05-25
PL170627B1 (en) 1997-01-31
CA2116356C (en) 1998-03-31

Similar Documents

Publication Publication Date Title
FI114707B (fi) Menetelmä terapeuttisesti käyttökelpoisten 3'-kinuklidinyyli-2-(hydroksimetyyli)-2-fenyylialkanoaattijohdannaisten valmistamiseksi ja välituote
CZ20033296A3 (cs) Benzoylsulfonamidy a sulfonylbenzamidiny jako protinádorové sloučeniny
SI9111647A (en) Unsaturated hydroxyalkylquinoline acids
AU593039B2 (en) Phenoxyalkylcarboxylic acids and esters and their preparation and pharmaceutical formulation
PT1442030E (pt) Tiofenossulfonamidas e tiazolessulfonamidas como agentes antineoplásicos
PT86459B (pt) Processo para a preparacao de derivados de cumarano substituidos naposicao 3
JP2021501184A (ja) P2x3及び/又はp2x2/3受容体アンタゴニスト、それを含む医薬組成物及びその使用
CN103180288B (zh) 具有生物学特性的二萜类衍生物
CA3112073A1 (en) Aromatic compounds and pharmaceutical uses thereof
EP0150461B1 (de) Schwefelhaltige 6-Ketoprostaglandine
EP4419509A1 (en) Compounds and compositions for treating conditions associated with lpa receptor activity
JP4826983B2 (ja) シクロヘプタ[b]ピリジン−3−カルボニルグアニジン誘導体およびそれを含有する医薬品
JPS6124388B2 (ru)
JP2009501723A (ja) 抗不整脈前駆体化合物、合成方法、及び使用方法
US20230339911A1 (en) Pyridazinone compounds
CN111138422B (zh) 一种用于防治红斑狼疮的药物及其制备方法
DE4021437A1 (de) Azulenderivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
WO2022222686A1 (zh) 木脂素衍生物、其制备方法及用途
US5177102A (en) Polyisoprene compounds and salts thereof
WO2024112895A1 (en) Compounds and compositions for treating conditions associated with lpa receptor activity
DK165920B (da) Selektive biologisk aktive 7-oxo-prostacyclinderivater og fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
WO1986002637A1 (en) Benzoic acid derivatives and process for their preparation
JP2003089688A (ja) イミダゾリン化合物

Legal Events

Date Code Title Description
MA Patent expired